A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Discover real-time Cytokinetics, Incorporated Common Stock (CYTK) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Cytokinetics Incorporated(CYTK) $43.770.34(0.78%) Bid:43.63x200Ask:43.78x200 March 10, 2025 10:06 AMEDTVolume: 197,308 USDNasdaq Global SelectDelayed Price Earnings High Target Price 120.00 Mean Target Price 79.30 Low Target Price 60.00
Goldman Sachs analyst revisits Rivian stock price target after Q4 earnings Rivian's R2 SUV, which is expected to challenge Tesla's Model Y, will launch early next year. RIVN Latest Commodity Market News Feb 20, 2025 4:37 PM EST